$237 Million Molecular Quality Controls Market by Product, Analyte Type, Application and End-user - Global Forecast to 2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 14, 2019--The “Molecular Quality Controls Market by Product (Independent, Instrument Specific), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.
The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period.
The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, an increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support.
However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are expected to restrain the growth of this market during the forecast period.
The infectious diseases segment held the largest share of the molecular controls market in 2018
Based on application, the molecular controls market is divided into four major segments - infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment accounted for the largest share of the molecular controls market in 2018.
The large share of this segment is attributed to the development of advanced assays for different infectious diseases, a significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of MDx technologies or products to control the occurrence and spread of infectious diseases.
Asia Pacific projected to grow at the highest CAGR during the forecast period.
The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.
- Increasing Number of Accredited Clinical Laboratories
- Growing Adoption of Third-Party Quality Controls
- Rising Demand for External Quality Assessment Support
- Additional Costs Involved in Quality Control and Budget Constraints in Hospitals & Laboratories
- Unfavorable Reimbursement Scenario for Molecular Tests
- Rising Demand for Multi-Analyte Controls
- Lack of Mandatory Regulations for Clinical Laboratory Accreditation in Several Emerging Countries
- Complex Regulatory Frameworks
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
3 Executive Summary
4 Premium Insights
4.1 Molecular Quality Controls: Market Overview
4.2 Molecular Quality Controls Market, By Product
4.3 North America: Molecular Quality Controls Market, By End User (2018)
5 Market Overview
6 Molecular Quality Controls Market, By Product
6.2 Independent Controls
6.3 Instrument-Specific Controls
7 Molecular Quality Controls Market, By Analyte Type
7.2 Single-Analyte Controls
7.3 Multi-Analyte Controls
8 Molecular Quality Controls Market, By Application
8.2 Infectious Diseases
8.4 Genetic Testing
8.5 Other Applications
9 Molecular Quality Controls Market, By End User
9.2 Clinical Laboratories
9.4 IVD Manufacturers and Contract Research Organizations
9.5 Academic & Research Institutes
9.6 Other End Users
10 Molecular Quality Controls Market, By Region
10.2 North America
10.4 Asia Pacific
10.5 Rest of the World
11 Competitive Landscape
11.1 Market Overview
11.2 Market Ranking Analysis, 2017
11.3 Competitive Benchmarking
12 Company Profiles
12.1 Seracare Life Sciences Inc.
12.2 Thermo Fisher Scientific
12.3 Bio-Rad Laboratories
12.4 Microbiologics Inc.
12.6 Roche Diagnostics
12.7 Abbott Laboratories
12.10 Maine Molecular Quality Controls Inc.
For more information about this report visit https://www.researchandmarkets.com/research/8d499k/237_million?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190214005828/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: RESEARCH SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/14/2019 02:28 PM/DISC: 02/14/2019 02:28 PM